Robert Coleman
罗伯特·科尔曼
MD, FACOG, FACS
Professor, Department of Gynecologic Oncology and Reproductive Medicine妇科肿瘤与生殖医学系教授
👥Biography 个人简介
Internationally renowned gynecologic oncologist at MD Anderson Cancer Center, with expertise spanning cytoreductive surgery and systemic therapy for ovarian cancer. Led the PAOLA-1 trial and was principal investigator for pivotal niraparib and bevacizumab combination trials.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
PARP Inhibitor and Bevacizumab Combination
Co-led the PAOLA-1 trial demonstrating olaparib plus bevacizumab maintenance benefit in advanced ovarian cancer, informing first-line maintenance standards.
Niraparib Trials
Served as lead investigator for PRIMA/ENGOT-OV26, establishing niraparib maintenance as standard of care in all-comers with newly diagnosed advanced ovarian cancer.
Cytoreductive Surgery
Advanced techniques of primary and interval debulking surgery, defining the role of surgical completeness in ovarian cancer outcomes.
Representative Works 代表性著作
Veliparib with first-line chemotherapy and as maintenance therapy in ovarian cancer (VELIA)
New England Journal of Medicine (2019)
Demonstrated PARP inhibitor embedded in chemotherapy and as maintenance improved PFS in BRCA-mutated advanced ovarian cancer.
Niraparib in newly diagnosed advanced ovarian cancer (PRIMA)
New England Journal of Medicine (2019)
Established niraparib maintenance benefit across HRD and non-HRD patient populations in newly diagnosed ovarian cancer.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Bradley J. Monk
University of Arizona / HonorHealth
Kathleen N. Moore
Stephenson Cancer Center, University of Oklahoma
Ana Oaknin
Vall d'Hebron University Hospital
Shannon Neville Westin
The University of Texas MD Anderson Cancer Center
关注 罗伯特·科尔曼 的研究动态
Follow Robert Coleman's research updates
留下邮箱，当我们发布与 Robert Coleman（University of Texas MD Anderson Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment